Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients’ lives. Our unwavering commitment to advancing patient care is demonstrated every day. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success. Headquartered in Dublin, Ireland with locations in California and Pennsylvania, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. Jazz Pharmaceuticals markets a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.
Press Releases
Nov 09 2015 - 4:06 p.m.
Jazz Pharmaceuticals Announces Third Quarter 2015 Financial Results
Nov 04 2015 - 4:06 p.m.
Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences
Oct 26 2015 - 4:06 p.m.
Jazz Pharmaceuticals to Report 2015 Third Quarter Financial Results on November 9, 2015


Sign up to receive e-mail alerts whenever Jazz Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.